However, emerging evidence linking angiopoietin-like protein 2 with chronic inflammation in RA, atherosclerosis, diabetes, and cancer47, and reports of fibroleukin regulating DC maturation51 and macrophage activation52, support the idea of immunomodulatory roles for FRePs. This evidence concerns the gene ANGPTL2 and atherosclerosis.